Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report.

Smit, Egbert F

Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer May 2010 - 719-20 p. digital

Publication Type: Journal Article

1556-1380

10.1097/JTO.0b013e3181d86ebf doi


Adenocarcinoma--drug therapy
Adenocarcinoma, Bronchiolo-Alveolar--drug therapy
Adult
Aged
Antineoplastic Agents--therapeutic use
Benzenesulfonates--therapeutic use
Carcinoma, Large Cell--drug therapy
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Squamous Cell--drug therapy
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Mutation--genetics
Neoplasm Staging
Niacinamide--analogs & derivatives
Phenylurea Compounds
Proto-Oncogene Proteins--genetics
Proto-Oncogene Proteins p21(ras)
Pyridines--therapeutic use
Sorafenib
Survival Rate
Treatment Outcome
ras Proteins--genetics